Polyestradiol phosphate

This classification denotes a therapeutic estradiol with the molecular formula ((C18H22O3P(C18H22O)n)n(C18H23O4P)n)co, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P14877CDX2, chemically known as 17-beta-estra 1,3,5(10)-triene-3,17-diol, 17-dihydrogen phosphate, homopolymer but generally known as polyestradiol phosphate, which bears US NIH Compound Identifier 66435. European Medicines Agency schedules Polyestradiol phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09973MIG. The term POLYESTRADIOL PHOSPHATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules polyestradiol phosphate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule polyestradiol phosphate under HS 29372300 and SITC 54153. As of Q4 2014, POLYESTRADIOL PHOSPHATE remains the US FDA Preferred Term for this commodity. Polyestradiol phosphate bears US NLM identifiers UMLS ID C0071554 and NCI Concept Code C1199. SMILES: CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O.OP(=O)(O)O.